Quality really matters: The need to improve specimen quality in biomedical research

Journal of Pathology

Volumn 228, Issue 4, 2012, Pages 431-433

  Simeon Dubach, Daniel ^a   Burt, Alastair D ^b   Hall, Peter A ^c,d  

^a Medservice   (Switzerland)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^d ALFAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Biomedical research standards; Biospecimen handling; BRISQ; Quality control

Indexed keywords

HISTOPATHOLOGY; MEDICAL LITERATURE; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; REVIEW; HEALTH CARE FACILITY; HUMAN; LABORATORY DIAGNOSIS; PATHOLOGY; STANDARDS; EDITOR; REPRODUCIBILITY; SAMPLE;

BIOLOGICAL SPECIMEN BANKS; BIOMEDICAL RESEARCH; GUIDELINES AS TOPIC; HUMANS; PATHOLOGY, CLINICAL; QUALITY CONTROL; SPECIMEN HANDLING;

EID: 84871236047     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4117     Document Type: Review

References (15)

1. Moore HM, Compton CC, Alper J, et al. International approaches to advancing biospecimen science. Cancer Epidemiol Biomarkers Prev 2011; 20: 729-732.
2. Compton C. Getting to personalized cancer medicine: Taking out the garbage. Cancer 2007; 110: 1641-1643.
3. Simeon-Dubach D, Perren A. Better provenance for biobank samples. Nature 2011; 475: 454-455.
4. Silberman S. Libraries of Flesh: The Story State of Human Tissue Storage. [Last accessed 18 September 2012]. Available from: Http://www.wired.com/ magazine/2010/05/ff-biobanks/2010
5. Massett HA, Atkinson NL, Weber D, et al. Assessing the need for a standardized cancer HUman Biobank (caHUB): Findings from a national survey with cancer researchers. J Natl Cancer Inst Monogr 2011; 42: 8-15.
6. Prinz F, Schlange T, Asadullah K. Believe it or not: How much can we rely on published data on potential drug targets? Nature Rev Drug Discov 2011; 10: 712.
7. Begley CG, Ellis LM. Drug development: Raise standards for preclinical cancer research. Nature 2012; 483: 531-533.
8. ISBER. 2012 Best practices for repositories: Collection, storage, retrival, and distribution of biological material for research. Biopreserv Biobank 2012; 10: 79-161.
9. Anonymous. Qualification Process for Drug Development Tools. Draft Guidance (US Department of Health and Human Services, FDA, CDER, October 2010). [Last accessed 18 September 2012]. Available from: Http://www.fda.gov/downloads/ Drugs/GuidanceCo mplianceRegulatoryInformation/Guidances/UCM230597.pdf. 2010
10. Groenen PJ, Blokx WA, Diepenbroek C, et al. Preparing pathology for personalized medicine: Possibilities for improvement of the preanalytical phase. Histopathology 2011; 59: 1-7.
11. Moore HM, Kelly AB, Jewell SD, et al. Biospecimen reporting for improved study quality (BRISQ). Biopreserv Biobank 2011; 9: 57-70.
12. Moore HM, Kelly A, McShane LM, et al. Biospecimen reporting for improved study quality (BRISQ). Clin Chim Acta 2012; 413: 1305.
13. Moore HM, Kelly AB, Jewell SD, et al. Biospecimen reporting for improved study quality (BRISQ). J Proteome Res 2011; 10: 3429-3438.
14. Moore HM, Kelly AB, Jewell SD, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 2011; 119: 92-101.
15. The BRISQ Report. [Last accessed 18 September 2012]. Available from: Http://obertools.pathology.ubc.ca/brisq/